Vagus Nerve Stimulator Sales in Europe to Exceed US$ 100 Million by 2019 Of the total global population inflicted by neurological disorders, approximately 50% suffers from an epileptic disorder, research and surveys say. Vagus nerve stimulation is witnessing a rapidly expanding applicability beyond epilepsy, in the recent past. Research uncovers potential efficiency of vagus nerve …
Author Archives: Editor AN
Prothrombin Complex Concentrates Market growth outlook seems modest with a CAGR of 3.5% during 2022-2028
A new study by the company titled ‘Prothrombin Complex Concentrates Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028’, has listed out the key points being considered by the companies operating in the prothrombin complex concentrates market to emerge and stay sustainably profitable in the long run. The North America prothrombin complex concentrates market is projected to expand …
Antibiotic Susceptibility Testing Market is expected to reach a valuation of US$ 4.05 Billion by 2028
Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST). Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening …
Retinal Biologics Market is expected to reach US$ 41.92 Billion by 2028
Retinal biologics market value surpassed US$ 14.6 billion in 2018 and projected to grow at 10.7% y-o-y in 2019, as per a new FMI study. The projected growth of the market can be attributed to, Increasing prevalence of diabetic eye diseases and age-related macular degeneration (AMD) Significant R&D investments engaged in developing biologics for infectious …
Continue reading “Retinal Biologics Market is expected to reach US$ 41.92 Billion by 2028”
Seasonal Affective Disorder Therapeutics Market is slated to rise at a CAGR of 4.3%, is projected to close in on US$ 1.1 Bn by the end of 2028
The seasonal affective disorder (SAD) therapeutics market is pegged at around US$ 450 million in 2019, with a modest Y-o-Y increase of 3.9% over 2018, according to a recent intelligence report by Future Market Insights. While drugs and devices collectively contribute to the consumption volume of seasonal affective disorder therapeutics, the latter will remain a major shareholder …
Over-the-Counter Pain Medication Market is predicted to rise at a CAGR of 4.1% from 2022 to 2028
The OTC (over-the-counter) pain medication market surpassed US$ 18 billion in 2018, with growth influenced by changing perceptions on generic pharmaceutical drugs, according to a recent study published by Future Market Insights (FMI). The study opines that market revenue will rev up at an improved rate of 3.7% to exceed US$ 19.3 billion in 2019. …
Generic Oncology Drugs Market is estimated to account for revenue of US$ 34.8 Billion by the end of 2028
Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of growth for the generic oncology drugs market and the cost pertaining to the treatment of cancer. Advanced technologies such as …
Metagenomics Market is anticipated to expand at a healthy CAGR of 7.1% between 2022 and 2028
According to a recently released report by Future Market Insights, widespread adoption of metagenomics tools in environmental monitoring and pollution reduction projects is estimated to boost the metagenomics market growth. Recent advancements in technology are aiding in the substantial reduction of costs incurred for sequencing paving way for the development of genetic sequencing on a large scale. This has opened …
Gastric Electric Stimulators Market is estimated to exceed US$ 291.1 Million by the end of 2026
The worldwide uptake of gastric electric stimulators is anticipated to witness hefty demand in 2019, representing a rigorous 6.6% y-o-y growth, while reaching a valuation of approx. US$ 188.4 Mn in 2026. As per Future Market Insights (FMI) report on gastric electric stimulators market for the forecast period 2018–2026, gastric electric stimulators’ demand is anticipated to be accelerated by …
Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is anticipated to attain a valuation of US$ 39.5 Billion by the end of 2028
The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028. The World Population Prospects’ data (2017) …